Prognos Revenue and Competitors
Estimated Revenue & Valuation
- Prognos's estimated annual revenue is currently $8.6M per year.
- Prognos's estimated revenue per employee is $121,800
- Prognos's total funding is $43.2M.
Employee Data
- Prognos has 71 Employees.
- Prognos grew their employee count by -22% last year.
Prognos's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | CFO & SVP | Reveal Email/Phone |
3 | Chief Technology Architect | Reveal Email/Phone |
4 | EVP, General Manager | Reveal Email/Phone |
5 | VP, Business Development, Lab Markets | Reveal Email/Phone |
6 | VP, Clinical Solutions | Reveal Email/Phone |
7 | VP, Life Science Solutions | Reveal Email/Phone |
8 | General Counsel & Chief Privacy Officer | Reveal Email/Phone |
9 | Chief Technology Officer | Reveal Email/Phone |
10 | Director Data Management & Implementations | Reveal Email/Phone |
Prognos Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $1.3M | 15 | 275% | N/A | N/A |
What Is Prognos?
Prognos is a healthcare AI company focused on eradicating disease by driving decisions earlier in healthcare in collaboration with payers, Life Sciences and diagnostics companies. The Prognos Registry is the largest source of clinical diagnostics information in over 30 disease areas, with over 5B medical records for 100M patients. Prognos has 500 extensive proprietary and learning clinical algorithms to enable earlier patient identification for enhanced treatment decision-making, risk management and quality improvement. The company is supported by a $23M investment from Safeguard Scientifics, Inc. (NYSE:SFE) and Merck Global Health Innovation Fund (GHIF). For more information, visit www.prognos.ai.
keywords:N/A
$43.2M
Total Funding
71
Number of Employees
$8.6M
Revenue (est)
-22%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Prognos News
Investors in the latest round include Cigna, Merck Global Health Innovation Fund, Hermed, Hikma Ventures, GIS Strategic Ventures, Maywic and Safeguard Scientifics. “We have seen Prognos’ capabilities first-hand and believe health plans will greatly benefit from integrating real-time lab and dia ...
Prognos, a NYC-based healthcare AI company, raised $20.5M in Series C funding. Backers included Cigna, GIS Strategic Ventures (the venture capital arm of the Guardian Life Insurance Company), Hermed, Hikma Ventures, Maywic, Merck Global Health Innovation Fund (GHI), and Safeguard Scientifics. ...
Prognos, a New York City-based healthcare Artificial Intelligence (AI) startup that has been steadfastly building its AI capabilities with the goal of predicting disease has raised $20.5 million in Series C funding. Particpatnts in the round include Cigna, GIS Strategic Ventures (the venture cap ...
Other Companies in New York
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $8.6M | 71 | 1% | $7.7M |
#2 | $3.5M | 71 | -3% | N/A |
#3 | $8M | 71 | -5% | $66.8M |
#4 | $340.8M | 71 | -3% | $9.3M |
#5 | $13M | 71 | -13% | $12.5M |